Home   Chapter Home   Jobs   Conferences   Fellowships   Books

 

 

 

 

Breast-malignant, males, children

WHO histological classification of tumors of the breast

 

Author: Nat Pernick, M.D, PathologyOutlines.com, Inc.

Reviewer: Daniel Visscher, M.D., University of Michigan Hospitals, February 2009 (see Reviewers page)

Revised: 4 September 2009

Last major update: September 2009

Copyright: (c) 2002-2009, PathologyOutlines.com, Inc.

 

Background

=========================================================================

● Reflects views of Working Groups that convened in Lyon, France in January and March 2002

● Publication: Tavassoli: Tumours of the Breast and Female Genital Organs (WHO, 2003)

● Also listed below are ICD-O (morphology code) and behavior code: /0 for benign, /1 for borderline or uncertain, /2 for in situ and grade 3 intraepithelial neoplasia, /3 for malignant

 

Epithelial Tumors

=========================================================================

● Invasive ductal carcinoma, not otherwise specified (NOS) - 8500/3

   Mixed type carcinoma

   Pleomorphic carcinoma - 8022/3

   Carcinoma with osteoclastic giant cells - 8035/3

   Carcinoma with choriocarcinomatous features

   Carcinoma with melanotic features

● Invasive lobular carcinoma - 8520/3

● Tubular carcinoma - 8211/3

● Invasive cribriform carcinoma - 8201/3

● Medullary carcinoma - 8510/3

● Mucinous carcinoma and other tumours with abundant mucin

   Mucinous carcinoma - 8480/3

   Cystadenocarcinoma and columnar cell mucinous carcinoma - 8480/3

   Signet ring cell carcinoma - 8490/3

● Neuroendocrine tumours

   Solid neuroendocrine carcinoma

   Atypical carcinoid tumour - 8249/3

   Small cell / oat cell carcinoma - 8041/3

   Large cell neuroendocrine carcinoma - 8013/3

● Invasive papillary carcinoma - 8503/3

● Invasive micropapillary carcinoma - 8507/3

● Apocrine carcinoma - 8401/3

● Metaplastic carcinomas - 8575/3

   Pure epithelial metaplastic carcinomas - 8575/3

      Squamous cell carcinoma - 8070/3

      Adenocarcinoma with spindle cell metaplasia - 8572/3

      Adenosquamous carcinoma - 8560/3

      Mucoepidermoid carcinoma - 8430/3

   Mixed epithelial/mesenchymal metaplastic carcinomas - 8575/3

● Lipid-rich carcinoma - 8314/3

● Secretory carcinoma - 8502/3

● Oncocytic carcinoma - 8290/3

● Adenoid cystic carcinoma - 8200/3

● Acinic cell carcinoma - 8550/3

● Glycogen-rich clear cell carcinoma - 8315/3

● Sebaceous carcinoma - 8410/3

● Inflammatory carcinoma - 8530/3

● Lobular neoplasia

   Lobular carcinoma in situ - 8520/2

● Intraductal proliferative lesions

   Usual ductal hyperplasia

   Flat epithelial atypia

   Atypical ductal hyperplasia

   Ductal carcinoma in situ - 8500/2

● Microinvasive carcinoma

● Intraductal papillary neoplasms

   Central papilloma - 8503/0

   Peripheral papilloma - 8503/0

   Atypical papilloma

   Intraductal papillary carcinoma - 8503/2

   Intracystic papillary carcinoma - 8504/2

● Benign epithelial proliferations

   Adenosis including variants: sclerosing adenosis, apocrine adenosis, blunt duct adenosis,

      microglandular adenosis, adenomyoepithelial adenosis

   Radial scar / complex sclerosing lesion

   Adenomas

      Tubular adenoma - 8211/0

      Lactating adenoma - 8204/0

      Apocrine adenoma - 8401/0

      Pleomorphic adenoma - 8940/0

      Ductal adenoma - 8503/0

 

Myoepithelial lesions

=========================================================================

● Myoepitheliosis

● Adenomyoepithelial adenosis

● Adenomyoepithelioma - 8983/0

● Malignant myoepithelioma - 8982/3

 

Mesenchymal Tumors

=========================================================================

● Hemangioma - 9120/0

● Angiomatosis

● Haemangiopericytoma - 9150/1

● Pseudoangiomatous stromal hyperplasia

● Myofibroblastoma - 8825/0

● Fibromatosis (aggressive) - 8821/1

● Inflammatory myofibroblastic tumour - 8825/1

● Lipoma - 8850/0

   Angiolipoma - 8861/0

● Granular cell tumour - 9580/0

● Neurofibroma - 9540/0

● Schwannoma - 9560/0

● Angiosarcoma - 9120/3

● Liposarcoma - 8850/3

● Rhabdomyosarcoma - 8900/3

● Osteosarcoma - 9180/3

● Leiomyoma - 8890/0

● Leiomyosarcoma - 8890/3

 

Fibroepithelial Tumors

=========================================================================

● Fibroadenoma - 9010/0

● Phyllodes tumour - 9020/1

   Benign - 9020/0

   Borderline - 9020/1

   Malignant - 9020/3

● Periductal stromal sarcoma, low grade - 9020/3

● Mammary hamartoma

 

Tumors of the nipple

=========================================================================

● Nipple adenoma - 8506/0

● Syringomatous adenoma - 8407/0

● Paget disease of the nipple - 8540/3

 

Malignant lymphoma

=========================================================================

● Diffuse large B cell lymphoma - 9680/3

● Burkitt lymphoma - 9687/3

● Extranodal marginal-zone B-cell lymphoma of MALT type - 9699/3

● Follicular lymphoma - 9690/3

 

Metastatic tumors - Tumors of the male breast

=========================================================================

● Gynaecomastia

● Carcinoma

   Invasive - 8500/3

   In situ - 8500/2

 

End of Breast – Malignant, Males, Children > WHO histological classification of tumors of the breast

 

 

 

This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment.  This website should not be used as a substitute for the advice of a licensed physician.

 

All information on this website is protected by Copyright, (c) 2001-2009, PathologyOutlines.com, Inc.  Information from third parties may also be protected by copyright.  Please contact us at copyrightPathOut@gmail.com with any questions.